Drug profile · INN
enzalutamide
ENZALUTAMIDE ACCORDPHARMA
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
enzalutamide (ENZALUTAMIDE ACCORDPHARMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN enzalutamide
Brand ENZALUTAMIDE ACCORDPHARMA
Route ORAL
Formulation CAPSULE
ATC code L02BB04
Related patents
Search patents →Frequently asked questions
What is enzalutamide?
enzalutamide (ENZALUTAMIDE ACCORDPHARMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for enzalutamide?
ENZALUTAMIDE ACCORDPHARMA is a marketed brand name for enzalutamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of enzalutamide?
enzalutamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.